Teva Pharmaceutical Industries total liabilities and share holders equity for the quarter ending June 30, 2024 was $41.338B, a 4.08% decline year-over-year.
Teva Pharmaceutical Industries total liabilities and share holders equity for 2023 was $43.479B, a 1.21% decline from 2022.
Teva Pharmaceutical Industries total liabilities and share holders equity for 2022 was $44.011B, a 7.67% decline from 2021.
Teva Pharmaceutical Industries total liabilities and share holders equity for 2021 was $47.666B, a 5.87% decline from 2020.
Teva Pharmaceutical Industries Total Liabilities and Share Holders Equity 2010-2024 | TEVA